Recent advances in the genetics and pathogenesis of Parkinson disease

Neurology

Volumn 58, Issue 2, 2002, Pages 179-185

  Maral Mouradian, M ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; GENE PRODUCT; LEVODOPA; OXIDIZING AGENT; PARKIN; PROTEASOME; UBIQUITIN; UBIQUITIN CARBOXY TERMINAL HYDROLASE L1; UNCLASSIFIED DRUG;

DISEASE COURSE; DOPAMINERGIC NERVE CELL; ENVIRONMENTAL FACTOR; GENE FUNCTION; GENE LOCUS; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HEREDITY; HUMAN; LEWY BODY; MEDICAL GENETICS; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; REVIEW; SUBSTANTIA NIGRA;

EID: 0037154184     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.58.2.179     Document Type: Review

References (62)

1. Prevalence of parkinsonism and Parkinson's disease in Europe: The EUROPARKINSON Collaborative Study. European community concerted action on the epidemiology of Parkinson's disease
2. The role of inheritance in sporadic Parkinson's disease: Evidence from a longitudinal study of dopaminergic function in twins
3. Mutation in the alpha-Synuclein gene identified in families with Parkinson's disease
4. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
5. The ubiquitin pathway in Parkinson's disease
6. Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese
7. Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family
8. A susceptibility locus for Parkinson's disease maps to chromosome 2p13
9. A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor
10. Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36
11. PARK7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36
12. Proteasomal function is impaired in substantia nigra in Parkinson's disease
13. Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-Synuclein
14. Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr alpha-Synuclein mutation
15. Ala30Pro mutation in the gene encoding alpha-Synuclein in Parkinson's disease
16. alpha-Synuclein in Lewy bodies
17. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch
18. Mice lacking alpha-Synuclein display functional deficits in the nigrostriatal dopamine system
19. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded
20. Fibrils formed in vitro from alpha-Synuclein and two mutant forms linked to Parkinson's disease are typical amyloid
21. alpha-Synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease
22. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-Synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy
23. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
24. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice
25. Dopaminergic loss and inclusion body formation in alpha-Synuclein mice: Implications for neurodegenerative disorders
26. A Drosophila model of Parkinson's disease
27. Tripartite management of unfolded proteins in the endoplasmic reticulum
28. The ubiquitin system
29. Degradation of alpha-Synuclein by proteasome
30. Rat alpha-Synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex
31. Inducible expression of mutant alpha-Synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis
32. The A53T alpha-Synuclein mutation increases iron-dependent aggregation and toxicity
33. Enhanced vulnerability to oxidative stress by alpha-Synuclein mutations and C-terminal truncation
34. alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro
35. Impairment of the ubiquitin-proteasome system by protein aggregation
36. The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: Is NAC a common trigger or target in neuro-degenerative disease?
37. Synphilin-1 associates with alpha-Synuclein and promotes the formation of cytosolic inclusions
38. Direct binding and functional coupling of alpha-Synuclein to the dopamine transporters accelerate dopamine-induced apoptosis
39. alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins
40. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease
41. Antibodies to alpha-Synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease
42. alpha-Synuclein in neurodegenerative disorders: Murderer or accomplice?
43. alpha-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy
44. Association between early-onset Parkinson's disease and mutations in the parkin gene
45. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
46. RING finger proteins: Mediators of ubiquitin ligase activity
47. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1
48. Ubiquitination of a new form of α-Synuclein by parkin from human brain: Implications for Parkinson's disease
49. An unfolded putative transmembrane polypeptide, which can-lead to endoplasmic reticulum stress, is a substrate of parkin
50. The septin CDCrel-1 binds syntaxin and inhibits exocytosis
51. Isolation of PGP 9.5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis
52. Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease
53. Expression of alpha-Synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: Genes associated with familial Parkinson's disease
54. Parkinsonism-inducing neurotoxin MPP+: Uptake and toxicity in nonneuronal COS cells expressing dopamine transporter cDNA
55. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease
56. Impaired iron homeostasis in Parkinson's disease
57. Hydroxyl radical attack on dopamine
58. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
59. Apoptotic signaling in dopamine-induced cell death: The role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases
60. Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway
61. Oxidative damage linked to neurodegeneration by selective alpha-Synuclein nitration in synucleinopathy lesions
62. alpha-Synuclein gene haplotypes are associated with Parkinson's disease